Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down 0.05% Nasdaq Down 0.19%
Streaming
Ticker Tape: On

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS

6.38 Down 0.10(1.54%) 1:59PM EDT - Nasdaq Real Time Price

Add to Portfolio
Prev Close:6.48
Open:6.46
Bid:6.37 x 1100
Ask:6.38 x 600
1y Target Est:10.57
Beta:2.69
Next Earnings Date: 7-Aug-13OREX Earnings announcement
Day's Range:6.30 - 6.47
52wk Range:3.10 - 7.73
Volume:555,161
Avg Vol (3m):1,127,500
Market Cap:603.82M
P/E (ttm):N/A
EPS (ttm):-1.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXDown 1.54%603.82M
NVODown 0.56%90.98B
TEVADown 0.89%33.38B
AGNUp 0.08%29.05B
FRXDown 1.29%10.44B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):178.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-0.79
Quarterly EPS Est (Jun-13) :-0.19
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.51

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback